Aegle Therapeutics

Funding and NIH signals

• SEC Form D raise Raised $2.28M (Form D filed Aug 28, 2026); +1 other Form D filing in the last 12 months. SEC Form D 0001797825-26-000007 (Aug 28, 2026)
  Evidence (2 events)

  • Aug 28, 2026 · SEC Form D 0001797825-26-000007
    Name of Issuer: Aegle Therapeutics Corp; CIK: 1797825; Address: Woburn, MA; Submission type: D; Filing date: 2026-08-28; Industry Group: Biotechnology; Date of First Sale: 2026-08-04; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 2277698; Total Amount Sold: 2277698; Federal exemptions: 06b
  • Mar 3, 2026 · SEC Form D 0001231919-26-000232
    Name of Issuer: Aegle Therapeutics Corp; CIK: 1797825; Address: Woburn, MA; Submission type: D; Filing date: 2026-03-03; Industry Group: Biotechnology; Date of First Sale: 2025-12-30; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 700000; Total Amount Sold: 455695; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals